Marco Casteleijn

Dr. Marco Casteleijn

VTT Technical Research Centre of Finland, Espoo, Uusimaa, Finland
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Progress in Retinal and Eye Research
Verified
Journal Article
Open access
EAEva Maria del Amo
Eva Maria del Amo
ARAnna-Kaisa Rimpelä
Anna-Kaisa Rimpelä
EHEmma Heikkinen
Emma Heikkinen
OKOtto K. Kari
Otto K. Kari
EREva Ramsay
Eva Ramsay
AUArto Urtti
Arto Urtti
Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many diseases affect the retina and choroid leading to impaired vision or blindness. Currently, intravitreal injections are the method of choice to administer drugs to the retina, but this approach is applicable only in selected cases (e.g. anti-VEGF antibodies and soluble receptors). There are two basic approaches that can be adopted to improve retinal drug delivery: prolonged and/or retina targeted delivery of intravitreal drugs and use of other routes of drug administration, such as periocular, suprachoroidal, sub-retinal, systemic, or topical. Properties of the administration route, drug and delivery system determine the efficacy and safety of these approaches. Pharmacokinetic and pharmacodynamic factors determine the required dosing rates and doses that are needed for drug action. In addition, tolerability factors limit the use of many materials in ocular drug delivery. This review article provides a critical discussion of retinal drug delivery, particularly from the pharmacokinetic point of view. This article does not include an extensive review of drug delivery technologies, because they have already been reviewed several times recently. Instead, we aim to provide a systematic and quantitative view on the pharmacokinetic factors in drug delivery to the posterior eye segment. This review is based on the literature and unpublished data from the authors' laboratory.

18 November 2008 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
JPJohanna Panula-Perälä
Johanna Panula-Perälä
JŠJuozas Šiurkus
Juozas Šiurkus
AVAntti Vasala
Antti Vasala
RWRobert Wilmanowski
Robert Wilmanowski
Marco CasteleijnMarco Casteleijn
Marco Casteleijn
Peter NeubauerPeter Neubauer
Peter Neubauer
Background: Here we describe a novel cultivation method, called EnBase™, or enzyme-based-substrate-delivery, for the growth of microorganisms in millilitre and sub-millilitre scale which yields 5 to 20 times higher cell densities compared to standard methods. The novel method can be directly applied in microwell plates and shake flasks without any requirements for additional sensors or liquid supply systems. EnBase is therefore readily applicable for many high throughput applications, such as DNA production for genome sequencing, optimisation of protein expression, production of proteins for structural genomics, bioprocess development, and screening of enzyme and metagenomic libraries. Results: High cell densities with EnBase are obtained by applying the concept of glucose-limited fed-batch cultivation which is commonly used in industrial processes. The major difference of the novel method is that no external glucose feed is required, but glucose is released into the growth medium by enzymatic degradation of starch. To cope with the high levels of starch necessary for high cell density cultivation, starch is supplied to the growing culture suspension by continuous diffusion from a storage gel. Our results show that the controlled enzyme-based supply of glucose allows a glucose-limited growth to high cell densities of OD600 = 20 to 30 (corresponding to 6 to 9 g l-1 cell dry weight) without the external feed of additional compounds in shake flasks and 96-well plates. The final cell density can be further increased by addition of extra nitrogen during the cultivation. Production of a heterologous triosphosphate isomerase in E. coli BL21(DE3) resulted in 10 times higher volumetric product yield and a higher ratio of soluble to insoluble product when compared to the conventional production method. Conclusion: The novel EnBase method is robust and simple-to-apply for high cell density cultivation in shake flasks and microwell plates. The potential of the system is that the microbial growth rate and oxygen consumption can be simply controlled by the amount (and principally also by the activity) of the starch-degrading enzyme. This solves the problems of uncontrolled growth, oxygen limitation, and severe pH drop in shaken cultures. In parallel the method provides the basis for enhanced cell densities. The feasibility of the new method has been shown for 96-well plates and shake flasks and we believe that it can easily be adapted to different microwell and deepwell plate formats and shake flasks. Therefore EnBase will be a helpful tool especially in high throughput applications.

4 August 2016 in Journal of Biosciences
Verified
Journal Article
Closed access
PDF file
CCChetan Chandola
Chetan Chandola
SKSheetal Kalme
Sheetal Kalme
Marco CasteleijnMarco Casteleijn
Marco Casteleijn
AUArto Urtti
Arto Urtti
MNMuniasamy Neerathilingam
Muniasamy Neerathilingam

1 January 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Marco CasteleijnMarco Casteleijn
Marco Casteleijn
AUArto Urtti
Arto Urtti
SSSanjay Sarkhel
Sanjay Sarkhel

1 September 2004 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
DLDion M.A.M. Luykx
Dion M.A.M. Luykx
Marco CasteleijnMarco Casteleijn
Marco Casteleijn
WJWim Jiskoot
Wim Jiskoot
JWJanny Westdijk
Janny Westdijk
PJPeter M.J.M. Jongen
Peter M.J.M. Jongen

1 December 2006 in Biochemistry
Verified
Journal Article
Closed access
Marco CasteleijnMarco Casteleijn
Marco Casteleijn
MAMarkus Alahuhta
Markus Alahuhta
KGKatrin Groebel
Katrin Groebel
ITIbrahim Tantawy
Ibrahim Tantawy
KAKoen Augustyns
Koen Augustyns
RWRik K. Wierenga
Rik K. Wierenga